MedPath

Red Queen Therapeutics, Inc.

Red Queen Therapeutics, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2021-01-01
Employees
-
Market Cap
-
Website
http://redqueentx.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

Phase 1
Completed
Conditions
SARS CoV 2 Infection
Infectious Disease
Symptomatic COVID-19 Infection Laboratory-Confirmed
COVID-19
First Posted Date
2023-10-02
Last Posted Date
2024-01-11
Lead Sponsor
Red Queen Therapeutics, Inc.
Target Recruit Count
66
Registration Number
NCT06063330
Locations
🇺🇸

LA Universal Research Center, Inc., Los Angeles, California, United States

🇺🇸

Florida International Medical Research, Miami, Florida, United States

🇺🇸

University of Maryland School of Medicine, Baltimore, Maryland, United States

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.